Robin Swartz

Swartz has served as Voyager’s Chief Operating Officer since 2022. She joined the company in 2021 as Senior Vice President, Portfolio Management and Patient Engagement. Prior to joining Voyager, she held several leadership positions at Genzyme. She most recently served as Vice President, Patient and Product Services for Rare Diseases and has held various additional positions including as Senior Vice President, Head of Global and US Business Operations, Chief of Staff to the Executive Vice President, and Senior Director, Finance. Swartz served on the Sanofi Aventis Board of Directors and was a member of the Executive Community Relations Committee. Swartz received her B.A. in political science from Kenyon College and is pursuing an M.P.H. at Yale University.